Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies

NCT00472056 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Carmustine
DRUG: Etoposide
DRUG: Cytarabine
DRUG: Melphalan
DRUG: Rituximab

Sponsor

M.D. Anderson Cancer Center